rs1555211935
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1_SupportingPM5_SupportingPP3PM2_Supporting
This summary comes from the ClinGen Evidence Repository: The c.710A>C variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of asparagine to threonine at codon 237 (p.(Asn237Thr)) of NM_000545.8. This variant is located within a conserved region of the DNA binding domain (codons 107-174 and 201-280) of HNF1A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.888, which is greater than the MDEP threshold of 0.70 (PP3). Another missense variant, c.709A>G (p.Asn237Asp), has been classified as likely pathogenic by the ClinGen MDEP (PM5_Supporting). In summary, c.710A>C meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved September 30, 2021): PM1_Supporting, PM2_Supporting, PM5_Supporting, PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA386965452/MONDO:0015967/017
Frequency
Consequence
ENST00000257555.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNF1A | NM_000545.8 | c.710A>C | p.Asn237Thr | missense_variant | 3/10 | ENST00000257555.11 | NP_000536.6 | |
HNF1A | NM_001306179.2 | c.710A>C | p.Asn237Thr | missense_variant | 3/10 | NP_001293108.2 | ||
HNF1A | NM_001406915.1 | c.710A>C | p.Asn237Thr | missense_variant | 3/9 | NP_001393844.1 | ||
HNF1A | XM_024449168.2 | c.710A>C | p.Asn237Thr | missense_variant | 3/9 | XP_024304936.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNF1A | ENST00000257555.11 | c.710A>C | p.Asn237Thr | missense_variant | 3/10 | 1 | NM_000545.8 | ENSP00000257555 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 04, 2016 | - - |
Monogenic diabetes Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Monogenic Diabetes Variant Curation Expert Panel | Apr 12, 2022 | The c.710A>C variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of asparagine to threonine at codon 237 (p.(Asn237Thr)) of NM_000545.8. This variant is located within a conserved region of the DNA binding domain (codons 107-174 and 201-280) of HNF1A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.888, which is greater than the MDEP threshold of 0.70 (PP3). Another missense variant, c.709A>G (p.Asn237Asp), has been classified as likely pathogenic by the ClinGen MDEP (PM5_Supporting). In summary, c.710A>C meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved September 30, 2021): PM1_Supporting, PM2_Supporting, PM5_Supporting, PP3. - |
Maturity onset diabetes mellitus in young Other:1
Uncertain risk allele, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs1555211935 with MODY3. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at